John P. Saharek
Former President and Chief Executive Officer, ImprimisRx
CEO
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Harrow, Inc. (HROW) | Former President and Chief Executive Officer, ImprimisRx Division | $475,614 | $727,421 |
| 2024 | Harrow, Inc. (HROW) | President and Chief Executive Officer, ImprimisRx | $463,431 | $743,467 |
| 2023 | Harrow, Inc. (HROW) | President and Chief Executive Officer, ImprimisRx | $431,463 | $5,815,154 |
| 2022 | Harrow, Inc. (HROW) | Chief Commercial Officer; Chief Executive Officer and President, ImprimisRx | $378,955 | $656,887 |
| 2021 | Harrow, Inc. (HROW) | Chief Commercial Officer and President, ImprimisRx | $347,308 | $2,676,858 |
| 2020 | Harrow, Inc. (HROW) | President, ImprimisRx | $316,731 | $533,538 |
| 2019 | Harrow, Inc. (HROW) | President, ImprimisRx | $290,122 | $963,798 |
Executive changes
-
Appointed President and Chief Executive Officer of the Company's ImprimisRx division at Harrow, Inc. (HROW)2024-01-02
Earnings-call appearances
No earnings-call appearances recorded yet.